Scilex Holding Co. (SCLX)
5.21
+0.17
(+3.37%)
USD |
NASDAQ |
Sep 21, 16:00
5.21
0.00 (0.00%)
After-Hours: 20:00
Scilex Enterprise Value : 138.69M for Sept. 18, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 18, 2026 | 138.69M |
| September 17, 2026 | 141.01M |
| September 16, 2026 | 139.61M |
| September 15, 2026 | 137.92M |
| September 14, 2026 | 139.12M |
| September 11, 2026 | 138.48M |
| September 10, 2026 | 138.76M |
| September 09, 2026 | 139.82M |
| September 08, 2026 | 141.01M |
| September 04, 2026 | 141.33M |
| September 03, 2026 | 140.38M |
| September 02, 2026 | 140.87M |
| September 01, 2026 | 141.23M |
| August 31, 2026 | 141.89M |
| August 28, 2026 | 141.44M |
| August 27, 2026 | 142.42M |
| August 26, 2026 | 142.70M |
| August 25, 2026 | 142.98M |
| August 24, 2026 | 143.05M |
| August 21, 2026 | 143.55M |
| August 20, 2026 | 144.04M |
| August 19, 2026 | 142.98M |
| August 18, 2026 | 147.84M |
| August 17, 2026 | 148.26M |
| August 14, 2026 | 150.79M |
| Date | Value |
|---|---|
| August 13, 2026 | 150.65M |
| August 12, 2026 | 151.78M |
| August 11, 2026 | 150.44M |
| August 10, 2026 | 150.30M |
| August 07, 2026 | 152.13M |
| August 06, 2026 | 152.06M |
| August 05, 2026 | 149.10M |
| August 04, 2026 | 148.75M |
| August 03, 2026 | 149.39M |
| July 31, 2026 | 150.12M |
| July 30, 2026 | 149.67M |
| July 29, 2026 | 149.39M |
| July 28, 2026 | 151.21M |
| July 27, 2026 | 152.69M |
| July 24, 2026 | 151.36M |
| July 23, 2026 | 155.22M |
| July 22, 2026 | 152.69M |
| July 21, 2026 | 158.39M |
| July 20, 2026 | 156.98M |
| July 17, 2026 | 162.61M |
| July 16, 2026 | 165.07M |
| July 15, 2026 | 168.10M |
| July 14, 2026 | 164.86M |
| July 13, 2026 | 169.65M |
| July 10, 2026 | 169.93M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Oramed Pharmaceuticals, Inc. | 145.95M |
| Semnur Pharmaceuticals, Inc. | 126.61M |
| ANI Pharmaceuticals, Inc. | 1.984B |
| Corcept Therapeutics, Inc. | 11.60B |
| Veru, Inc. | 17.98M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -116.22M |
| Revenue (Quarterly) | 7.642M |
| Total Expenses (Quarterly) | 122.37M |
| EPS Diluted (Quarterly) | -16.65 |
| Gross Profit Margin (Quarterly) | 14.73% |
| Profit Margin (Quarterly) | -1.52K% |
| Earnings Yield | -955.9% |
| Normalized Earnings Yield | -640.68 |